Clinical Trial Update: Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating left atrial appendage occluders after catheter ablation for atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Left Atrial Appendage Occluder

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED